NRC Health
Business Overview: National Research Corporation (NASDAQ: NRC)
Executive Summary
National Research Corporation, doing business as NRC Health, is a Delaware corporation headquartered at 1245 Q Street, Lincoln, Nebraska. Founded in 1981, NRC Health has spent more than four decades building what it calls a "Human Understanding®" platform: subscription-based healthcare experience management and market research tools used by hospitals, health systems, and payers to measure and improve how patients, consumers, and employees experience care.
The company earns the large majority of its revenue from renewals of multi-year subscription agreements with healthcare provider clients, giving it a highly recurring revenue base (99% of FY2025 revenue was recurring). It most directly competes with Press Ganey and Qualtrics, both of which it describes as having significantly higher revenue than NRC Health.
NRC Health matters because U.S. healthcare reimbursement and quality-reporting frameworks (such as CMS's CAHPS patient-experience surveys) create a regulatory and operational need for standardized, benchmarked patient and consumer experience measurement — a need NRC Health has served continuously since the 1980s, even as the business has recently faced elevated client attrition and renewed competitive and growth pressure.
1. Core Business Model & How They Work
NRC Health sells subscription access to a suite of survey, analytics, and benchmarking platforms to healthcare provider organizations. Revenue is driven by Total Recurring Contract Value (TRCV) — the sum of active subscription contracts — rather than one-off project fees, and renewals (not new logo sales alone) have historically made up most revenue.
[Healthcare provider/ [NRC Health subscription: [Hospital/health
payer client signs --> survey data collection + --> system uses insights
multi-year subscription benchmarking vs. national to improve patient
agreement] database of ~300,000 experience, CAHPS
consumers/year + AI tools compliance scores,
(Huey AI)] employee engagement]
|
v
[Client renews subscription at
contract end -> recurring revenue
(99% of FY2025 revenue);
client attrition = key risk]
2. Business Segments
National Research Corporation (NRC Health)
|
---------------------------------------------------------------------------
| | | | | |
Market Patient Employee Consumer Reputation Huey AI /
Experience Experience Experience Experience Solutions Governance
| | | | | Institute (TGI)
Market Cross- Engagement Feedback Star ratings |
Insights continuum tools, dept.- capture + publication & AI companion
survey of digital level Community online for healthcare
~300,000 patient analytics Insights reputation experience +
consumers/yr feedback | custom monitoring membership/
+ brand/ad platform, | research | research
measurement CAHPS- | | | services for
compliant, | | | not-for-profit
care | | | health system
transition boards/execs
The 10-K does not disclose revenue by individual product line, so the diagram above reflects product/offering structure rather than audited segment revenue shares; NRC Health reports as a single operating segment in its financial statements, with the above representing its named platform offerings rather than distinct reportable financial segments.
3. Product Portfolio
| Offering | Category | Purpose | Why It Matters |
|---|---|---|---|
| Market Insights | Market Experience | Syndicated survey of ~300,000 U.S. healthcare consumers annually, covering brand perception and selection drivers | Proprietary national dataset competitors would need years to replicate; supports benchmarking that is central to the subscription value proposition |
| Patient Experience Platform | Patient Experience | Cross-continuum digital feedback platform, CAHPS-compliant survey methods, care-transition and discharge follow-up tools | Directly tied to CMS quality-reporting/reimbursement requirements, embedding NRC Health into clients' regulatory compliance workflows |
| Employee Experience | Employee Experience | Engagement surveys and department-level analytics | Expands wallet share within existing hospital system clients beyond patient-facing measurement |
| Consumer Experience / Community Insights | Consumer Experience | General feedback capture and custom consumer research | Broadens NRC Health's data footprint beyond active patients to the general healthcare consumer population |
| Reputation Solutions | Reputation Management | Publishes star ratings and monitors online reputation | Addresses the growing importance of public online reviews in patient choice of provider |
| Huey AI | AI Platform | AI-driven "healthcare experience management companion" | Represents NRC Health's response to AI disruption risk and a potential new differentiator versus larger but less healthcare-specialized rivals like Qualtrics |
| The Governance Institute (TGI) | Membership/Research | Conferences, research, and membership services for not-for-profit health system boards and executives | Diversifies revenue into governance/board-level relationships, deepening institutional ties beyond the experience-measurement product line |
4. Competitive Landscape
NRC Health names Press Ganey and Qualtrics as its primary competitors, both explicitly described in its own 10-K as having significantly higher revenue than NRC Health. The company also competes against healthcare organizations' internal research/quality departments, which can choose to perform patient-experience measurement in-house rather than outsourcing it. NRC Health states plainly that "there are relatively few barriers to entry into our market" and that many competitors have greater financial and marketing resources — an unusually candid admission of competitive vulnerability directly from the filing.
Healthcare-specific focus
|
NRC Health *|*
(Human Understanding,
healthcare-only database)
|
Smaller/niche ------------------------- Larger/broader enterprise scale
research shops |
Press Ganey (healthcare-focused,
larger revenue base)
|
Qualtrics (broad enterprise
experience-management platform,
much larger, cross-industry)
General-purpose enterprise focus
NRC Health's positioning is as the smaller, more healthcare-specialized player in a market where both of its named competitors are larger; its differentiation rests on decades of healthcare-specific benchmarking data and deep CAHPS/regulatory-compliance integration rather than scale.
5. Strategic Strengths & Risks
Strengths (Moat Sources):
- Proprietary national benchmarking database (Market Insights' ~300,000 consumers surveyed annually, built over decades) gives clients comparative context that a new entrant cannot replicate quickly.
- Deep embedding in regulatory compliance workflows (CAHPS-compliant patient experience surveys tied to CMS reimbursement) makes NRC Health's platform operationally difficult to rip out mid-contract.
- Extremely high recurring revenue mix (99% of FY2025 revenue), reflecting genuine subscription stickiness even amid recent attrition.
- Decades-long client relationships and brand recognition ("Human Understanding®") within hospital C-suites and boards (reinforced by The Governance Institute's board-level relationships).
Risks:
- Explicitly low barriers to entry: the company itself states there are "relatively few barriers to entry" into its market, an unusual and material self-disclosed competitive risk.
- Elevated client attrition: management attributed FY2025's revenue decline (down 4% to $137.4 million) directly to "elevated client attrition in the second half of 2024," which continued to weigh on comparisons into 2025, with Q4 2025 revenue down 5% YoY and the stock falling roughly 27% on the Q4 2025 report.
- Scale disadvantage versus named competitors: both Press Ganey and Qualtrics are described as having significantly higher revenue, and Qualtrics in particular brings broader enterprise cross-industry resources and AI investment capacity.
- Revenue decline trend: revenue has fallen in each of the last several fiscal years (from $151.6M in FY2022 to $137.4M in FY2025), even though Total Recurring Contract Value has recently begun growing again (+8% to $144.1M, per Q4 2025 commentary), creating uncertainty about whether the turnaround is durable.
- AI disruption risk: generalized AI tools could commoditize parts of survey design and analytics that previously required NRC Health's specialized platform, though the company's own Huey AI product is a direct response to this risk.
6. Financial Overview
| Metric | FY2025 Figure | Strategic Context |
|---|---|---|
| Revenue | $137.4 million (down ~4% YoY, down from $151.6M in FY2022) | Multi-year revenue decline is the central investor concern despite high recurring mix |
| Gross Margin | ~61.9% (vs. ~60.2% FY2024, ~62.4% FY2023) | High and fairly stable gross margin confirms the underlying subscription software/data economics remain intact even as top-line shrinks |
| Operating Income | $29.4 million (down from $46.6M in FY2022) | Operating leverage has worked in reverse as revenue has declined, pressuring profitability more than margin percentage suggests |
| Net Income | $11.6 million (down from $31.8M in FY2022) | Net income decline reflects both lower revenue and one-time costs (e.g., CEO transition compensation expected in 2025) |
| Recurring Revenue Mix | 99% of FY2025 revenue | Core evidence that the subscription model itself remains structurally sound despite attrition |
| Capital Return | $11.3 million in dividends declared (2024) plus ongoing share repurchases | Signals management confidence in cash generation even amid revenue softness, though down sharply from $36.3M in dividends in 2023 |
7. Summary Conclusion
NRC Health's moat is built on a genuinely hard-to-replicate asset — a decades-deep, healthcare-specific national benchmarking database — paired with deep integration into CMS-linked regulatory compliance workflows that make its subscription product sticky once embedded in a hospital's quality-reporting processes. That said, the company's own 10-K candidly flags relatively low barriers to entry, and recent results (multi-year revenue decline, elevated client attrition through 2024-2025, and scale disadvantages versus larger competitors Press Ganey and Qualtrics) show that stickiness has not been absolute. The biggest forward risk is whether recent green shoots — Total Recurring Contract Value returning to sequential growth and new sales activity up sharply year-over-year per management's Q4 2025 commentary — translate into an actual revenue inflection, or whether continued attrition and competitive pressure from larger, better-resourced rivals keep NRC Health on its multi-year downward revenue trajectory.